| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.0033 | 1 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.0097 | 1 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.013 | 1 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.005 | 1 |